Skip to main content

News Archive

News Archive - Yadira Galindo

Genetic Tool Improves Estimation of Prostate Cancer Risk in Diverse Ethnic/Racial Groups

February 23, 2021

Scientists at University of California San Diego School of Medicine validated a more inclusive and comprehensive genetic tool, known as a polygenic hazard score (PHS), for predicting age of onset of aggressive prostate cancer.

UC San Diego Health Opens Vaccination Site on University Campus

February 2, 2021

UC San Diego Health will open a new COVID-19 vaccination site on the main campus of University of California San Diego, serving vaccination-eligible UC San Diego Health patients as well as UC San Diego faculty and staff.

UC San Diego Health Opens Vaccination Site on University Campus

February 2, 2021

UC San Diego Health will open a new COVID-19 vaccination site on the main campus of University of California San Diego, serving vaccination-eligible UC San Diego Health patients as well as UC San Diego faculty and staff.

When — Not What — Obese Mice Ate Reduced Breast Cancer Risk

January 25, 2021

University of California San Diego School of Medicine and Moores Cancer Center researchers report that intermittent fasting reduced breast cancer risk in obese mice.

Youth Using E-cigarettes Three Times as Likely to Become Daily Cigarette Smokers

January 10, 2021

University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Science researchers report that starting tobacco products, including e-cigarettes, before the age of 18 is a major risk factor for people becoming daily cigarette smokers.

UC San Diego Selected to Lead International HIV/AIDS Clinical Trials Unit

November 30, 2020

University of California San Diego has been selected by the NIH to lead and administer an international seven-year, $28-million grant for HIV/AIDS clinical trials.

Active Surveillance Safe for African Americans with Low-Risk Prostate Cancer

November 3, 2020

Researchers with UC San Diego School of Medicine and Moores Cancer Center say active surveillance is safe for African American men with low-risk prostate cancer.

Personalized Cancer Therapy Improves Outcomes in Advanced Disease, Says Study

October 2, 2020

Patients receiving care for advanced cancer at Moores Cancer Center at UC San Diego Health were more likely to survive or experience a longer period without their disease progressing if they received personalized cancer therapy.

Lost in Transition: Sickle Cell Clinic Helps Adults Continue Care

September 29, 2020

Networking California for Sickle Cell Care Initiative supports expansion of San Diego’s only adult sickle cell disease clinic at UC San Diego Health which offers child-to-adult transition health services to patients like Vanessa Hughes.

Genetic Testing Cost Effective for Newly Diagnosed GIST

September 28, 2020

UC San Diego School of Medicine researchers reported that genetic testing is cost-effective and beneficial for newly diagnosed patients with metastatic gastrointestinal stromal tumors (GIST), a rare type of cancer.
Category navigation with Social links